HIV heterosexual transmission: A hypothesis about an additional potential determinant  by Louria, Donald B. et al.
Perspective 
HIV Heterosexual Transmission: 
A Hypothesis About an Additional Potential Determinant 
Donald B. Louria, MD;* Joan H. Skurnick, PhD;* Paul Palumbo, MD;+ John D. Bogden, PhD;* 
Christine Rohowsky-Kochan, MD;+ Thomas N. Denny, BS;+ and Cheryl A. Kennedy, MD* 
Transmission rates of human immunodeficiency virus 
(HIV) during heterosexual intercourse vary dramatically 
around the world. In Asia and South America,le3 they are 
extraordinarily high, whereas in the United States and 
Europe, rates are much lower even after a large number 
of unprotected contacts. 4-9 The transmission rates in 
Africa also probably are high, but the available studies 
unfortunately are weak. ‘OJ~ In Thailand, female-to-male 
transmission rates per contact were estimated at .056 
(l in 18) compared to .0002 to .0015 (l/5000-l.S/lOOO) 
for male-to-female transmission in the United States and 
Europe.‘,*x9 Male-to-female transmission in Thailand 
appears to show, as expected, even greater transmission 
likelihood compared to female-to-male rates.” In general, 
in the United States and Europe, transmission rates within 
heterosexual couples range from less than 10% to 22%, 
whereas in Thailand and Brazil, the rates exceed 
40%.2.3~4~9912 The much lower transmission rate per contact 
in the United States and Europe is based on an assump- 
tion that HIV transmitters are a homogeneous group. 
Wiley and colleagues argue that transmitters are likely to 
be a heterogeneous group with a large percentage of 
very low frequency transmitters and a small percentage 
of high frequency transmitters.13 That hypothesis is given 
some support by a cluster of cases in rural New York 
State in which one man appeared to infect 31% of his 
many contacts.‘* 
Explanations for the remarkable differences in per- 
contact transmission among Europe, the United States, 
Asia, Africa, and South America include: 
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1. Rates of ulcerative sexually transmitted diseases 
(STDs), 
2. Rates of non-ulcerative STDs, 
3. Iypes of sexual practices, 
4. Infecting clades, 
5. Viral loads, 
6. Viral phenotypes (e.g., syncytium formation), 
7. Host cell susceptibilities, and 
8. Genetic patterns. 
SEXUALLY TRANSMITTED DISEASES 
The evidence is clear that STDs promote HIV transmis- 
sion The clinical and epidemiologic data in Africa and 
Asia are most persuasive for the effects of genital ulcer 
disease, particularly chancroid, herpes simplex virus II 
(HSV), and syphilis. 15,16 In the United States, chancroid 
occurs rarely and syphilis rates are at an all time low.” 
The lower transmission rates in the United States could 
be explained in part by lower rates of ulcerative STDs, 
but it should be noted that, in one study in Thailand, 
female-to-male HIV transmission rates were much higher 
per contact for men who had no history of STDs, com- 
pared to the per-contact risk in the United States.’ The 
higher per-contact risk among men without STDs could 
have been related to STDs among the HIV-positive female 
partners; female STD prevalence was not included in the 
analysis.’ Another study from Thailand showed a 41% 
transmission rate among women who had no history of 
STDs; in that study, STDs among the HIV-positive part- 
ners were not found to be a significant factor.* 
Although ulcerative STDs are definite risk factors for 
HIV transmission, the role of non-ulcerative STDs is far 
less clear. In the authors’ studies comparing serodiscor- 
dant heterosexual couples in whom transmission had 
not occurred with seroconcordant couples in whom 
transmission had occurred, both herpes II antibody 
prevalence and antibody against Mycoplasma geni- 
talium increased transmission likelihood two- to three- 
fold in the absence of either a history of or physical 
examination evidence of genital tract infection. l8 These 
antibody results with HSV confirm one previous study,19 
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but are in disagreement with another report.*’ The M 
genitdium observation is new and requires confirmation 
by other investigators. 
Some investigators believe the increased transmis- 
sion rates, at least in Africa, can be explained almost com- 
pletely by genital ulcer disease and lack of circumcision.1o 
This may be true, but those studies focused on commer- 
cial sex workers and STD clinics and may not apply to the 
general population. Padian et aL5 in a lo-year prospec- 
tive study in the United States, estimated the per-contact 
transmission rate to be about 1 in 1000. They also noted 
that the most significant risk factor for transmission was 
a history of STDs; however, the odds ratio of 2.6 for STDs 
could not explain the huge disparity in transmission rates 
between her cohort and those studied in Brazil and 
Thailand. 
Detection and treatment of STDs appeared to reduce 
HIV incidence dramatically in Tanzania and Thailand.*lm2’ 
But in the Thailand study, anti-STD campaigns were 
accompanied by intensive education programs designed 
to promote less promiscuity and safer sex; this obscures 
the role of STD detection and treatment. A recent large 
and well-conducted study in Uganda did not confii the 
effectiveness of detection and treatment of five common 
STDs in reducing HIV transmission.24 
In addition to the increased risk accompanying STDs, 
the practice of dry sex (inserting a variety of substances, 
including antiseptics, detergents, and herbs into the 
vagina prior to intercourse) may produce such extensive 
local irritation and inflammation that transmission of HIV 
is enhanced.25 This practice, largely in parts of Africa, 
would not explain the high transmission rates in Asia and 
South America. 
OTHER VARIABLES 
Viral load is an independent risk factor for transmis- 
sion 26-29 but there are no rigorously derived data show- 
ing that viral load is substantially higher in areas of the 
world in which HIV transmission rates are greater. Viral 
compartmentalization is likely to be a key issue, which, 
again, has not been rigorously addressed. It is clear from 
multiple studies that many viral properties (e.g., quan- 
tity, phenotype, and genotype) may vary among com- 
partments such as blood, genital tract, and the central 
nervous system (CNS). In the absence of direct and 
definitive studies within the appropriate compartment, 
in this case, the genital tract, it will be difficult to estab- 
lish the role of viral properties in transmucosal trans- 
mission. In addition, it is not clear whether 
cell-associated or cell-free virus is the vehicle for het- 
erosexual transmission. Despite acknowledged limita- 
tions, the relation between quantitative virology 
measurements and infection status remains a significant 
independent variable in multivariate analyses. Still there 
is no reason to believe that higher viral load in higher 
transmission areas by itself accounts for the much 
higher transmission rates. 
Another key factor in initiation of infection is the 
host cell at the site of exposure to Hn! the mucosal sur- 
face. Although it is clear that cells of immune origin (e.g., 
dendritic cells, CD4 lymphocytes) are early participants 
in acute infection, it is not certain what cell type or types 
orchestrate the first event. Epithelial cells generally pro- 
vide an effective barrier; whether they participate in some 
manner in the initiation of infection as initially infected 
host cells or whether the barrier must be breached phys- 
ically is open to investigation. The role or even the pres- 
ence of local antibody is unsettled as is the potential role 
of female hormonal status. Even if local antibody is impor- 
tant, as it may well be,30-32 there is no evidence that 
differences in local antibody account for the huge trans- 
mission rate discrepancies in different geographic areas. 
It has been suggested that clade E, responsible for much 
of the infection in some areas, has an increased ability to 
infect Langerhans’ cells and thus potentially has a greater 
capacity for mucosal invasion3’; that intriguing observa- 
tion remains unsubstantiated. At present, the existing data 
do not permit the conclusion that clade differences in 
pathogenic&y account in any substantial way for geo- 
graphic differences in HIV transmission. 
Since the discovery of chemokine receptors as sec- 
ond cell receptors for HIV binding and uptake, poly- 
morphisms, particularly in the B-chemokine receptor 5 
(CCRS), have been recognized that influence infectivity 
and disease progression. These include the CCR5 [A]32 
mutation and polymorphisms in the promoter region of 
CCR5.34.3i The CCR5 [A]32 mutation is most prevalent 
in Caucasian populations, and homozygosity for this muta- 
tion virtually protects individuals from tmnsmucosal infec- 
tion despite intense exposure. However, it is not frequent 
in populations in which HIV is most prevalent and, there- 
fore, has limited impact on disease transmission world- 
wide. The CCR5 promoter mutations, some of which are 
prevalent in black and Hispanic populations, only recently 
have been recognized and have been shown to signiti- 
cantly impact the risk for vertical transmission.35 Further 
studies are awaited regarding the impact of CCR5 pro- 
moter polymorphism in relation to horizontal transmis- 
sion and disease progression. These polymorphisms could 
have significant impact, owing to their diffuse penetrance 
worldwide, and they could help explain geographic dif- 
ferences in heterosexual transmission rates. 
Syncytium-forming HIV strains or variants and other 
viral phenotypes are associated with faster progression of 
established disease.27.36-38 This has been implicated as a 
risk factor for both horizontal and vertical transmis- 
sion.39,40 However, the authors found no evidence that 
syncytium formation was a determinant of transmission 
in the heterosexual couples studyz9 
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The authors have found that the most critical deter- 
minant of nontransmission in heterosexual couples was 
a robust CD8 cell response in the HIV-positive member 
of the couple with both a greater number of such cells 
and evidence that these CD8 cells suppress HIV-l repli- 
cation by production of both noncytolytic substances 
and chemokines.29a41 Interestingly, in a small cohort of 
HIV-negative but highly exposed women, although there 
was no increase in numbers of CD8 cells, about half of 
the women showed HIV replication suppression with 
evidence that the CD8 cells produced both noncytolytic 
HIV-suppressive substances and chemokines.41~42 
A variety of studies suggest that in addition to CD8 
noncytolytic substances and chemokines, resistance may 
depend on CD4 cell proliferation in response to HIV anti- 
gens, cytotoxic lymphocyte activity, a TH,-type host 
response, or the production of neutralizing antibody.43-53 
Whether there are geographic differences in these puta- 
tive defenses is unknown. 
GENETIC PATTERNS 
Differences in transmission rates could be, in large part, 
genetically determined; the genetic makeup of HIV- 
positive individuals and exposed HIV-negative persons 
may play a major role in promoting or retarding HIV tram+ 
mission during sexual intercourse. The influence of 
genetic factors on the immune response to HIV-l is evi- 
denced in the following observations. First, the concor- 
dance rate for infection is higher among monozygotic 
twins born to HIV-l infected mothers than for dizygotic 
twins.54 Second, an association of host genetic factors 
with resistance to HIV-1 infection is suggested by the dif- 
ferences in infectivity of CD4 lymphocytes from different 
individuals to any specific HIV-1 strain.55 Third, resistance 
to murine acquired immunodeficiency syndrome varies 
among host strains and maps to the major histocompat- 
ibility complex H-2 complex, the mouse equivalent of 
the human leukocyte antigen (HLA) region.56 
The role of host HLA class I and II molecules in the 
susceptibility to HIV-l infection has been investigated 
in many studies. Analysis of the HLA complex in homo- 
sexuals, hemophiliacs, intravenous drug users, and in 
perinatally exposed infants has provided preliminary evi- 
dence that HLA genes may be involved in susceptibility 
to HIV-l infection, but there has been no consistency in 
regard to which specific HLA alleles confer greater sus- 
ceptibility.57-62 Studies of the influence of host HLA genes 
in susceptibility to HIV-l infection among heterosexual 
partners of infected individuals are limited. Two HLA-B 
locus antigens (B52 and B44) were reported to be asso- 
ciated with HIV resistance, whereas another HLA-B allele 
(B51) was associated with HIV susceptibility in a group 
consisting of heterosexual partners of HIV-l-positive drug 
abusers, children born to seropositive women, and hemo- 
philiacs. 60,63 The antigen DRll was significantly associ- 
ated with infectiousness of HIV-l-positive spouses in 
heterosexual couples and of HIV-l-positive mothers.@ 
Resistance in persistently negative female sex workers in 
Thailand was associated with an increased frequency of 
HLA-B18.32 The results of the authors’ study on the dis 
tribution of HLA molecules in HIV-l-infected individuals 
and their heterosexual HIV-seropositive or -seronegative 
partners showed that different HLA alleles were associ- 
ated with susceptibility or resistance to infection in indi- 
viduals of various ethnic backgrounds.64 In black and 
Hispanic individuals, the prevalence of DQ7 and Cw7 
was associated with susceptibility to HIV-l infection, 
whereas the frequency of DQ4 and B53 was associated 
with resistance to infectivity. No HLA associations were 
observed in the Caucasian heterosexual couples, perhaps 
owing to small sample size or heterogeneity of the group. 
The DQ7 allele is associated with several DR antigens, 
including DRll and DR12, both of which have been 
reported to be associated with susceptibility to HIV-l 
infection.65 
Major histocompatibility complex HLA molecules 
may influence the susceptibility or resistance to HIV-l 
infection by influencing the body’s ability to mount a 
protective antiviral cytotoxic Tcell (CTL) response. Cer- 
tain HLA class I molecules may present highly conserved 
(invariant among strains) epitopes, eliciting an efficient 
and protective CTL response. In contrast, other HLA mol- 
ecules may be restricting the CTL response to highly vari- 
able HIV epitopes. Such CTL responses against mutated 
HIV proteins may be ineffective in eliminating the virus 
and may be promoting transmission of HIV 
Evidence of the role of genes in the human major 
histocompatibility complex (i.e., HLA region) in the sus- 
ceptibility or resistance to HIV-l infection is growing, 
and it is likely that as yet unidentified susceptibility or 
resistance genetic factors will be discovered among pop- 
ulations with various ethnics backgrounds. 
The evidence supports a significant role in hetero- 
sexual HIV transmission or nontransmission for at least 
ulcerative STDs, viral loads, CD8 cell activities, host cell 
susceptibilities, and genetic predisposition or resistance. 
None of these determinants at present appears dominant 
as the critical variable in transmission or nontransmission. 
NUTRITION AND MICRONUTRIENTS 
The authors believe that a currently inadequately inves- 
tigated variable may be at least as important as any of 
the variables discussed; that is, the nutritional status of 
either the HIV-positive individual or the HIV-negative 
partner or both. 
Reliable country-wide micronutrient data are sur- 
prisingly sparse for most areas of the world, particu- 
larly for specific vitamins or trace elements known to 
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influence local or systemic resistance (e.g., folic acid, vit- 
amins C, B, and B,,, carotenoids, zinc, selenium). Data are 
available on poverty and malnutrition, vitamin A, iron, 
and iodine. 
Four hundred million people on this planet suffer 
from dire poverty; more than 800 million are malnour- 
ished, and another billion have more subtle nutritional 
defects. The areas of risk of malnutrition show remark- 
able similarity to world patterns of the worst of the bur- 
geoning or established HIV epidemics. Bailey and 
Ferro-Luzzi used body mass index to assess adult nutri- 
tional states.& In Europe and the United States, low body 
mass index was found in 3.5 to 5.1% of the population, 
whereas in Asia (minus China) the percentage was 
l2.3%, in India 48.6%, and in sub-Saharan Africa 10 to 
60%; all these latter areas currently suffer from major 
HlV epidemics and potentially increased transmission 
rates. Iron deficiency, another general index of nutritional 
status, was found in 4% of men 55 to 69 years of age 
and 8% of women 15 to 49 years of age in the United 
States. In contrast, the figures for developing countries 
were 26% for men and 37% for women. For southern 
Asia, the figures were 32% for men, 58% for women. In 
Africa, it was 20% for men, 44% for women. In recent 
decades, iron intake in many developing countries has 
actually decreased.67 
Vitamin A deficiency is extensive in many parts of 
Asia, India, and Africa.67 Retinol deficiency promotes the 
incidence and severity of certain infections, such as 
measles.6**69 It is estimated that micronutrient malnutri- 
tion of vitamin A, iodine, and iron affects 2 billion persons 
worldwide.‘0,71 There also is ample evidence, both exper- 
imental and clinical, that certain vitamin and trace ele- 
ment deficiencies (particularly vitamin A, folic acid, 
pyridoxine, iron, zinc, and selenium) interfere with T-cell 
functions.” This interference could increase viral load in 
HIV-positive individuals and decrease resistance to HN 
invasion in HIV-negative partners. 
There are now substantial data indicating that vitamin 
or trace element deficiencies promote progression of HIV 
infection. The evidence is best for vitamins A, E, B,, and 
B,,, glutathione, selenium, and zinc73-s1; however, there is 
little consistency among studies. The cross-sectional 
design of many of the studies makes it impossible to tell 
whether the measured deficits contribute to progression 
or whether they are manifestations of the effects of HIV 
on absorption, distribution, metabolism, or excretion of 
the vitamins and trace elements, thus reflecting the dis- 
ease progression rather than contributing to it. Glu- 
tathione blood and tissue concentrations appear to 
decline early after HIV infection and, thus, could con- 
tribute to cell damage and CD4 cell decline.82~83 Three 
separate studies indicate that plasma or erythrocyte mag- 
nesium concentrations also decline early in the course of 
the disease.82.R4,85 This decline cannot be explained either 
by alcohol intake or HIV-related diarrhea. Several 
intervention studies suggest that correction of certain 
nutritional deficits can slow disease progression.86-88 
There have been no studies on the role of nutritional 
deficits on horizontal HIV transmission, but vertical HIV 
transmission has been correlated with maternal vitamin 
A blood concentrations. Transmission rates from mother 
to child were found to be 7.2% in the top quartile of 
maternal blood vitamin A levels, 16% in the second quar- 
tile, 26% in the third quartile, and 32% in the lowest quar- 
tile.89 These levels were found to be independent of 
maternal CD4 levels. In all, 65% of these pregnant women 
were found to be vitamin A deficient. Fawzi et al studied 
HIV-positive pregnant women in Tanzaniago and found 
that one-third had low vitamin A levels at baseline. Admin- 
istration of a multivitamin decreased the frequency of 
low birth weight by 44% and resulted in a modest 
increase in maternal CD4 and CD8 cell counts. Interest- 
ingly, vitamin A supplementation had no such beneficial 
effects. Effects on infant HIV-positivity rates were not 
reported. 
Beck and colleagues have provided the experimen- 
tal underpinning for the concerns about nutritional sta- 
tusY1,‘* They made mice either vitamin E or selenium 
deficient and infected them with a strain of Coxsackie 
B with minimal cardiac pathogenic&y. In the nutritionally 
deprived mice, the Coxsackie B produced severe 
myocarditis. The virus was then re-isolated from heart 
muscle and injected into normal nutriture mice; sur- 
prisingly, severe myocarditis was again found even 
though the hosts were not nutritionally deprived. These 
phenotypic changes (increased virulence) were then 
shown to be attributable to genomic changes in the Cox- 
sackie B virus. Thus, the investigators showed convinc- 
ingly that nutritional deprivation (selenium or vitamin E 
deficiency) promoted mutations that resulted in a dra- 
matic increase in virulence. 
If these stunning studies showing that host moditi- 
cation can change the genetics of invading viruses are 
applicable to other microorganisms and to humans, the 
implications are extraordinary. In a world with billions 
of persons with inadequate nutriture, a variety of micro- 
organisms, passing through such hosts, may increase 
either in pathogenic&y or transmission potential. Human 
immunodeficiency virus, a virus with striking mutation 
capabilities, would be a prime candidate for mutation 
changes that promote transmission or virulence. 
The recent study from Uganda2* showing no reduc- 
tion in incidence of HIV in those treated for STDs com- 
pared to a control group has been viewed with 
considerable alarm. However, it should be noted that the 
infection rate in the controls was 25% less than antici- 
pated. The controls were given multivitamins as well as 
iron. An alternative explanation for apparent STD-treat- 
ment failure is that STD treatment in the intervention 
group and multivitamins in the control group each 
reduced the expected incidence by 25%. 
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If the nutritional status of the HIV-positive partner or 
the nutritional status of the uninfected, exposed partner 
is found to be a major factor in the likelihood of trans- 
mission, a variety of potential mechanisms could be 
involved. For example, nutritional deficits could increase 
viral load, thus increasing the potential for transmission. 
As in the experimental studies of Beck and colleagues,91xg2 
nutritional defects in either the HIV donor or the partner 
could enhance mutational changes in the virus that might 
increase the likelihood of transmission. Nutritional deficits 
also could alter local or systemic defenses or both and, 
thus, enhance the ability of the virus to invade local cells 
in the vagina. 
If nutritional deprivation is an important variable, 
the infection-nutrition interaction may establish a 
vicious, self-perpetuating cycle. Human immunodefi- 
ciency virus attacks young adults in a society, thereby 
reducing the productivity and stability of that society; in 
turn this increases the prevalence of undernutrition and 
malnutrition, and that could create larger numbers of 
hypersusceptible individuals and create the milieu for 
changes in the virus that could enhance transmission 
potential. 
There are three potential approaches to testing this 
hypothesis. One is to compare blood concentrations of 
vitamins and trace elements in concordant, as contrasted 
to discordant couples. This approach could be informa- 
tive if primary members of concordant, and the positive 
members of discordant couples are studied with careful 
matching for many variables, including age, duration of ill- 
ness, and immunologic status. Unfortunately, it would be 
difficult to compare the secondarily infected partner in 
concordant couples with the uninfected partner in dis- 
cordant couples because of the effects of HIY even early 
in the course of the disease, on host nutriture. 
A second approach is ecological-to examine vitamin 
and trace element population patterns in high HIV inci- 
dence and low incidence (high transmission vs. low trans- 
mission) geographic areas. Unfortunately, that approach 
has major difficulties in establishing causation. 
The third and most desirable approach is prospec- 
tive. A study could be carried out in geographic areas 
where the epidemic is emerging, for example, in India 
or China. A large number of reasonably high-risk men 
and women, analyzed for nutritional intake and blood lev- 
els of vitamins and trace elements, could then be fol- 
lowed prospectively for frequency of HIV acquisition. An 
intervention arm could be designed, providing one group 
with a daily nutritional supplement. Of course, there are 
daunting challenges to this type of study: controlling 
appropriately for relevant variables; addressing the POS- 
sibility the nutritional deficit in total caloric intake rather 
than specific vitamins or specific trace elements; decid- 
ing whether the intervention should be a mixture of vit- 
amins and trace elements (and if so which ones) or less 
well defined but potentially more effective extracts of 
fruits and vegetables; controlling for other major risk fac- 
tors including STDs, disease stage, and viral load of HIV- 
positive sexual partners; and above all, ensuring adequate 
follow-up and compliance with the intervention regimen. 
Despite their limitations, studies using the second and 
third approaches could provide insight into the relation 
between nutrition and HIV transmission. 
If specific nutritional deficiencies enhance HIV trans- 
mission, then, while awaiting the development of an effec- 
tive vaccine, a potentially important and inexpensive 
approach to limiting the severity of the epidemic would 
be available-providing populations in high transmission 
risk areas with a daily nutritional supplement. 
At the very least, this hypothesis deserves careful and 
urgent attention, and it needs to be tested. 
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